Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy
Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine
The hospital is being developed at a cost of more than Rs. 1,575 crore
They also released the Operational Guidelines for Wellness activities at AB-HWCs
As per 10th edition of International Diabetes Federation (IDF) Atlas, 2021, India has 74.2 million people with diabetes between the age of 20-79 years
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
These satellite institutes will further strengthen the research, international collaborations and facilitate affordable Ayush services for the larger community.
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
More women centric initiatives being the need of the hour for holistic development
Subscribe To Our Newsletter & Stay Updated
